GVR Report cover Mammography Market Size, Share & Trends Report

Mammography Market Size, Share & Trends Analysis Report By Product (Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems), By Technology, By Application, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Aug, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-353-9
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 85

Report Overview

The global mammography market size was valued at USD 1.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.0% from 2021 to 2028. The rising prevalence of breast cancer and increasing demand for early-stage diagnosis amongst patients are some of the key factors anticipated to drive demand for breast cancer diagnostic devices over the forecast period. Increased access to breast cancer screening systems and growing government initiatives to support clinical interpretation are some of the pivotal factors expected to propel market growth. For instance, the Health Resources and Services Administration (HRSA) had introduced a healthcare program to increase the screening procedures in medically underserved areas.

U.S. mammography market size, by product, 2018 - 2028 (USD Million)

The COVID-19 pandemic has resulted in significant reductions in cancer screening, cancer management visits, and cancer procedures across the globe. The repercussions of delayed cancer detection owing to COVID-19 were investigated in a study undertaken in the U.K. and published in The Lancet Oncology in March 2021. The study covered data from over 100,000 people with breast, colorectal, esophageal, or lung cancer. The study found that 1 and 5-year cancer survival rates will be severely reduced because of the outbreak of COVID-19, owing to the lack of availability of screening services. As a result, owing to lockdowns, screening services have disrupted to some extent which may lower the demand for mammography systems. However, numerous physician reports from the U.S. have observed a growing number of screening appointments during the last quarter of 2020 which is expected to continually rise to reach pre-covid levels by the latter half of 2021.

The increasing incidence of breast cancer across the globe is one of the major factors responsible for the growth of the market for mammography. For instance, according to WHO, in 2018, around 627,000 women died due to breast cancer in 2018 globally, and it is also estimated that the rate of breast cancer is higher among women in developed regions as compared to developing regions. Moreover, according to Cancer Organization India, in 2018, breast and oral cavity cancer accounted for 25.0% of cancer cases in women. Furthermore, according to Susan G Komen Breast Cancer Foundation, Inc., in 2019, around 41,760 women are expected to die due to breast cancer. In addition, according to South African Journal of Radiology, in 2018, breast cancer is one of the most common types of cancer in South Africa in women and is also one of the leading causes of death.

The introduction of new products in the market is expected to boost the adoption rate among end-users. The earlier generations of mammography systems provided 2D images of the breast, which limits the interpretation quality. 2D mammography systems provide Craniocaudal (CC) and Mediolateral-Oblique (MLO) images. The flat nature of these images makes it difficult for physicians to interpret images and identify tumors due to overlapping of tissues and calcifications, which masks cancerous lesions. With the introduction of new 3D-based technology called Digital Breast Tomosynthesis (DBT), it is possible to obtain a 3D image of the breast. This allows radiologists to scan the breast slice by slice and identify abnormalities, which would be obscured in 2D images.

Product Insights

The digital systems segment dominated the mammography market and accounted for the largest revenue share of 61.6% in 2020 and is expected to witness considerable growth over the forecast period. Rising demand for technologically improved breast cancer screening systems is one of the main factors expected to drive the market. The 3D system is anticipated to be the fastest-growing segment with a CAGR of 11.9%. Government-issued Acts, such as Medical Imaging Modernization Act, 2015, ordained to promote technological advancements, resulted in a surge of demand for 3D systems.

The 3D systems segment is anticipated to be the fastest-growing segment over the forecast period. Owing to several advantages, hospitals, and diagnostic clinics are switching to 3D systems as 2D systems are often ineffective in detecting every sign of cancer, increasing the need for additional screenings, which, in turn, increases the overall diagnostic cost. The 3D systems market has become so competitive that companies such as Hologic have begun advertising their products directly to customers.

Technology Insights

In 2020, the digital mammography technology segment dominated the market and accounted for the maximum revenue share of more than 67.0% owing to the various advantages of the digital mammography technology. Technological advancements in the breast cancer screening devices market are anticipated to enhance the utilization and adoption of digital mammography. The breast tomosynthesis technology segment is expected to witness the fastest growth over the forecast period.

Global mammography market share, by technology, 2020 (%)

In addition, huge commercial availability and rising demand for mammography technology among healthcare professionals are factors driving the segment. Some of the key players operating majorly in this segment are Siemens Healthcare Private Limited and General Electric Company (GE Healthcare). In 1996, digital technology was introduced in these devices as a prototype technology. As of 2015, it has become a mature segment of the market.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 37.2% in 2020. The region is expected to exhibit a considerable growth rate over the forecast period. The rising incidence of breast cancer is one of the major factors driving the market in the region. In addition, the presence of highly developed healthcare infrastructure and increasing healthcare spending are among factors anticipated to drive the market in the region over the forecast period.

In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period. The presence of developing countries, such as China, and Japan, is anticipated to boost market growth in Asia Pacific region. In addition, key players are making constant efforts to enter emerging markets of Asia Pacific, which is expected to boost the market over the forecast period.

Key Companies & Market Share Insights

Hologic has a wide product portfolio, which includes breast tomosynthesis technology, digital mammography, computer-aided detection, and breast biopsy devices. The key participants are actively involved in multiple strategic initiatives to maintain their position in the market for mammography. For instance, in December 2020, Hologic Inc., a developer, producer, and provider of high-quality diagnostics, medical imaging devices announced U.S. FDA clearance for its Genius AI Detection technology, a new deep learning-based software designed to aid radiologists to detect subtle potential cancers in breast tomosynthesis images. Some of the prominent players in the mammography market include:

  • Hologic

  • Fujifilm

  • Siemens Healthcare

  • Phillips Healthcare

  • Toshiba Medical Systems

  • GE Healthcare

  • Metaltronica

  • I.M.S. Srl

Mammography Market Report Scope

Report Attribute


Market size value in 2021

USD 1.9 billion

Revenue forecast in 2028

USD 3.8 billion

Growth rate

CAGR of 10.0% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments covered

Product, technology, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; South Africa

Key companies profiled

Hologic; Fujifilm; Siemens Healthcare; Phillips Healthcare; Toshiba Medical Systems, GE Healthcare; Metaltronica; I.M.S. Srl

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global mammography market report on the basis of product, technology, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Film Screen Systems

    • Digital Systems

    • Analog Systems

    • Biopsy Systems

    • 3D Systems

  • Technology Outlook (Revenue, USD Million, 2016 - 2028)

    • Breast Tomosynthesis

    • CAD

    • Digital

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.